Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $3.05 in the prior trading day, Verve Therapeutics Inc (NASDAQ: VERV) closed at $3.26, up 6.89%. In other words, the price has increased by $6.89 from its previous closing price. On the day, 2.36 million shares were traded. VERV stock price reached its highest trading level at $3.31 during the session, while it also had its lowest trading level at $3.045.
Ratios:
Our goal is to gain a better understanding of VERV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.65 and its Current Ratio is at 12.65. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Kathiresan Sekar sold 9,822 shares for $4.15 per share. The transaction valued at 40,761 led to the insider holds 346,686 shares of the business.
Nickerson Joan sold 2,777 shares of VERV for $11,525 on Apr 02 ’25. The Chief Administrative Officer now owns 17,420 shares after completing the transaction at $4.15 per share. On Apr 02 ’25, another insider, Ashe Andrew D., who serves as the insider of the company, sold 2,681 shares for $4.15 each. As a result, the insider received 11,126 and left with 348,828 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 289474304 and an Enterprise Value of -164823792. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.95 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at -5.098 whereas that against EBITDA is 0.743.
Stock Price History:
The Beta on a monthly basis for VERV is 1.98, which has changed by -0.55403554 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, VERV has reached a high of $9.31, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -47.07%, while the 200-Day Moving Average is calculated to be -44.78%.
Shares Statistics:
The stock has traded on average 1.61M shares per day over the past 3-months and 2519660 shares per day over the last 10 days, according to various share statistics. A total of 88.76M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 25.54% of the company’s shares, while institutions hold 69.95% stake in the company. Shares short for VERV as of 1743379200 were 16629900 with a Short Ratio of 10.35, compared to 1740700800 on 14864938. Therefore, it implies a Short% of Shares Outstanding of 16629900 and a Short% of Float of 22.16.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
